TO

TEMITOPE ONAYEMI

THE RABEN GROUP · Washington, DC · registered since 2024
Registered · LDAActive

Background

Career
Washington, DC
2024 - present

Specific issues

Education on strengthening FDA authority and the safety of personal care products, including H.R. 3619 (Toxic-Free Beauty Act), H.R. 3620 (Cosmetic Safety for Communities of Color and Professional Salon Workers Act), H.R. 3621 (Cosmetic Fragrance and Flavor Ingredient Right to Know Act), H.R. 3622 (Cosmetic Supply Chain Transparency Act), proposals to regulate PFAS in cosmetic products, including H.R. 6519 (No PFAS in Cosmetics Act), and implementation of the Modernization of Cosmetics Regulation Act of 2022. Funding for Centers for Disease Control Biomonitoring program and National Health Tracking Network in Fiscal Year 2024. Proposals to reform the FDA's GRAS standard, reassess and ban food additives, and food packaging-related legislation, including H.R. 6105 (No Toxics in Food Packaging Act) and S.3387 (Ensuring Safe and Toxic-Free Foods Act).
Health Issues · 2024 Q4
Spectrum Policy 5G Deployment National 5G Artificial Intelligence Affordable Connectivity Program (ACP)
Communications/Broadcasting/Radio/TV · 2024 Q4

Clients

2024 · 3 filings
$██,███ / qtrUnlock

Filing history

2024 Q4
VERIZON
4Tlda.gov →
2024 Q4
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)
Q4lda.gov →
2024 Q3
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)
Q3lda.gov →
2024 Q3
VERIZON
Q3lda.gov →
2024 Q2
VERIZON
Q2lda.gov →
2024 Q2
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)
Q2lda.gov →
2024 Q1
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)
Q1lda.gov →
Showing recent filings · full history on lda.gov